Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

PURPOSE: The purpose of this study was to compare ramosetron (RAM), aprepitant (APR), and dexamethasone (DEX) [RAD] with palonosetron (PAL), APR, and DEX [PAD] in controlling highly-emetogenic chemotherapy (HEC)–induced nausea and vomiting. MATERIALS AND METHODS: Patients were randomly assigned (1:1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jin Hyoung, Kwon, Jung Hye, Lee, Yun-Gyoo, Park, Keon Uk, An, Ho Jung, Sohn, Joohyuk, Seol, Young Mi, Lee, Hyunwoo, Yun, Hwan-Jung, Ahn, Jin Seok, Yang, Ji Hyun, Song, Hunho, Koo, Dong-Hoe, Kim, Jin Young, Kim, Gun Min, Kim, Hwa Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373869/
https://www.ncbi.nlm.nih.gov/pubmed/32192275
http://dx.doi.org/10.4143/crt.2019.713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373869/
https://www.ncbi.nlm.nih.gov/pubmed/32192275
http://dx.doi.org/10.4143/crt.2019.713

Ejemplares similares